BioXcel Therapeutics (BTAI) PT Lowered to $95 at BMO Capital

August 14, 2020 3:05 PM EDT Send to a Friend

BMO Capital analyst Do Kim ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

BioXcel Therapeutics (BTAI) PT Lowered to $95 at BMO Capital

Member Login

Free News Feed